RhumbLine Advisers
BRNS

RhumbLine Advisers’s Barinthus Biotherapeutics BRNS Stock Holding History

RhumbLine Advisers’s Portfolio BRNS Stock Details BRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$72 Hold
2024
Q3 		$73 Hold
2024
Q2 		$84 Hold
2024
Q1 		$144 Hold
2023
Q4 		$213 Hold
2023
Q3 		$185 Buy